What is semi-supervised machine learning? And what could it mean for the research and development of AI-powered digital medical systems? Andrew Goulter reports on state-of-the art deep learning research that promises huge savings in the time and expense of development.
Author profile
アンドリュー ゴルター
Vice President of Life Sciences
Andrew has 20 years’ experience in the Life Sciences industry, including working in the biotech industry in drug development and product development and realisation companies developing scientific instrumentation and medical devices.